OZOP ENERGY SOLUTIONS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OZOP ENERGY SOLUTIONS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $157.5K | Apr 16, 2019 |
| FY2018 | Dec 31, 2017 | $56.6K | Apr 16, 2019 |
| FY2017 | Apr 30, 2017 | $26.6K | Jul 27, 2017 |
| FY2017 | Apr 30, 2016 | $7.5K | Jul 27, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.34M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $4.76M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $16.63M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $10.60M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.41M | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $492.1K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $157.5K | May 14, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $155.5K | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($606.9K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.35M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $831.9K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $7.1K | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $37.5K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $117.8K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $17.9K | Apr 16, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($6.20M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($7.37M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $6.03M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($195.05M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($20.97M) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($571.6K) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($2.49M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.41M) | Apr 16, 2019 |
| FY2017 | Apr 30, 2017 | ($34.5K) | Jul 27, 2017 |
| FY2017 | Apr 30, 2016 | ($9.1K) | Jul 27, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.46M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($6.25M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($4.61M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($12.61M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($17.58M) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($514.9K) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($1.44M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.34M) | Apr 16, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $183.9K | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $6.7K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $7.5K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Apr 26, 2022 |
| FY2019 | Dec 31, 2019 | $75.4K | May 14, 2020 |
| FY2019 | Dec 31, 2018 | $88.6K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $264.6K | Apr 16, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.85M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($799.3K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($8.60M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($6.35M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($1.81M) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($94.1K) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($835.4K) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($941.3K) | Apr 16, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $11.1K | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $2.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $65.2K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $108.9K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $46.4K | Apr 26, 2022 |
| FY2019 | Dec 31, 2018 | $7.6K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $1.9K | Apr 16, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.75M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $3.78M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $9.49M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $11.57M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.39M | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $1.05M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $659.2K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $122.2K | Apr 16, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $33.26M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $30.30M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $30.47M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $39.32M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $8.74M | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $2.28M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $3.01M | May 14, 2020 |
| FY2017 | Apr 30, 2017 | $56.2K | Feb 7, 2018 |
| FY2017 | Apr 30, 2016 | $65.9K | Feb 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($30.72M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($25.73M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($20.19M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($27.49M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($6.35M) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($1.23M) | Apr 15, 2021 |
| FY2020 | Dec 31, 2018 | ($661.8K) | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | ($1.42M) | May 14, 2020 |
| FY2017 | Apr 30, 2017 | ($15.0K) | Feb 7, 2018 |
| FY2018 | Dec 31, 2016 | ($9.6K) | Apr 16, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $11.20M | Apr 26, 2022 |
| FY2020 | Dec 31, 2020 | $11.20M | Apr 15, 2021 |
| FY2019 | Dec 31, 2019 | $2.20M | May 14, 2020 |
| FY2019 | Dec 31, 2018 | $239.2K | May 14, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($224.87M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($218.67M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($211.30M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($217.33M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($22.28M) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($1.31M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($4.07M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.58M) | Apr 16, 2019 |
| FY2017 | Apr 30, 2017 | ($43.6K) | Feb 7, 2018 |
| FY2017 | Apr 30, 2016 | ($9.1K) | Feb 7, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.45M | Apr 16, 2024 |
| FY2023 | Dec 31, 2022 | $1.37M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $6.63M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.81M | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $27.4K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $50.9K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $111.0K | Apr 16, 2019 |
| FY2017 | Apr 30, 2017 | $712 | Feb 7, 2018 |
| FY2018 | Dec 31, 2016 | $86.2K | Apr 16, 2019 |
| FY2017 | Apr 30, 2016 | $917 | Feb 7, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 7.09B | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | 5.48B | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 4.77B | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 4.62B | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 3.40B | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 29,068 | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 13.00M | Apr 16, 2019 |
| FY2017 | Apr 30, 2017 | 2.00M | Feb 7, 2018 |
| FY2017 | Apr 30, 2016 | 2.00M | Feb 7, 2018 |